Document is current
Any future updates will be listed below
-
Authors
Wendling, Daniel https://orcid.org/0000-0002-4687-5780
- License Information
-
More Information
Article History
Accepted: 17 September 2024
First Online: 10 October 2024
Declarations
:
: No funding.
: Financial interests: none. Long-term or permanent links: none. Occasional involvement: AbbVie, BMS, MSD, Pfizer, Nordic Pharma, UCB, Novartis, Lilly, Janssen and Galapagos. Indirect interests: Abbvie, MSD, UCB, Fresenius Kabi and Galapagos.
: Not applicable.
: Not applicable.
: Not applicable.
: The sole author performed literature research and analysis, writing of the manuscript and corrections.
